AL
TROW icon

Aspiriant LLC’s T. Rowe Price TROW Stock Holding History

Aspiriant LLC’s Portfolio TROW Stock Details TROW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-2,282
Closed -$248K – 251
2018
Q3 		$248K Sell
2,282
-94
-4% -$10.9K 0.02% 211
2018
Q2 		$276K Sell
2,376
-347
-13% -$40.3K 0.02% 209
2018
Q1 		$294K Buy
+2,723
New +$303K 0.03% 195
2017
Q4 		– Sell
-3,672
Closed -$333K – 170
2017
Q3 		$333K Sell
3,672
-4,423
-55% -$366K 0.03% 157
2017
Q2 		$601K Sell
8,095
-1,670
-17% -$119K 0.05% 135
2017
Q1 		$665K Sell
9,765
-982
-9% -$69.6K 0.06% 135
2016
Q4 		$809K Buy
+10,747
New +$761K 0.07% 117

Other funds holding TROW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Aspiriant LLC's TROW Position: Q4 2018 in Review

Aspiriant LLC sold out of T. Rowe Price (TROW) in Q4 2018, closing a stake of 2,282 shares — an estimated $248K sold.

Aspiriant LLC first reported a position in TROW in Q4 2016 and held it in 7 quarters. The position peaked at $809K in Q4 2016. 841 funds tracked by Wall St. Rank hold TROW as of Q4 2018.

  • Aspiriant LLC reported no remaining T. Rowe Price position as of Q4 2018 after selling out during the quarter.
  • Aspiriant LLC sold 2,282 T. Rowe Price shares in Q4 2018, an estimated $248K.
  • Aspiriant LLC first reported a position in T. Rowe Price in Q4 2016 and held it in 7 quarters.
  • Aspiriant LLC's T. Rowe Price position peaked at $809K in Q4 2016.
  • 841 funds tracked by Wall St. Rank held T. Rowe Price as of Q4 2018.

Based on Aspiriant LLC's 13F filing for Q4 2018, filed 4 Feb 2019.